Comprehensive Metabolic Panel Testing Market Size to Reach USD 22.97 Billion In 2028: Reports and Data
June 01, 2021 11:44 ET
|
Reports and Data
New York, June 01, 2021 (GLOBE NEWSWIRE) -- Market size: USD 12.59 Billion in 2020, Market Growth: CAGR of 7.8%, Market Trends: Rising demand for immediate diagnosis and growing adoption of CMP...
Metacrine to Present at 2021 Jefferies Healthcare Conference
May 26, 2021 08:05 ET
|
Metacrine, Inc.
SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal...
Metacrine Achieves Enrollment Target for MET642 Phase 2a Trial Interim Analysis
May 18, 2021 08:05 ET
|
Metacrine, Inc.
Interim data from the first 60 patients with NASH on track to be reported in the fourth quarter of 2021Enrollment continuing for up to 180 patients, with full topline results expected to be reported...
Metacrine Accelerates MET409 Clinical Development Milestone and Reports First-Quarter 2021 Results
May 13, 2021 16:05 ET
|
Metacrine, Inc.
• Topline results from a Phase 2a trial of MET409 in combination with empagliflozin in patients with NASH and type 2 diabetes now expected in the fourth quarter of 2021 • Interim data from the...
Metacrine Appoints Dr. Julia C. Owens to Its Board of Directors
April 05, 2021 16:05 ET
|
Metacrine, Inc.
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and...
Sonic Incytes Announces FDA Clearance and US Launch of Velacur™ to Help Manage Emerging Health Crisis
October 20, 2020 10:00 ET
|
Sonic Incytes Medical Corp.
VANCOUVER, British Columbia, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Sonic Incytes Medical Corporation is pleased to announce the US commercial release of VelacurTM, the world’s first handheld 3D liver...
North America Liver Disease Treatment Market to Hit $8.31 Billion by 2027: AMR
October 20, 2020 09:26 ET
|
Allied Market Research
Portland, OR, Oct. 20, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the North America Liver Disease Treatment Market accounted for $6.97 billion in 2019, and is...
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
January 21, 2020 09:15 ET
|
Ritter Pharmaceuticals, Inc.
Transaction to Create a Nasdaq-listed Biotechnology Company Focused on Advancing Qualigen’s Cancer and Infectious Disease Therapeutic Development Programs LOS ANGELES, Jan. 21, 2020 (GLOBE...
New Pharmacy Partnership Optimizes Patient Care Through Data Driven Solutions
January 21, 2020 07:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are...
Ontario Pharmacists and Avricore Health Partner to Expand HealthTab™ in Community Pharmacies and Enhance Patient Care
November 18, 2019 08:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are...